This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

It is well established that certain hormones induce, maintain, or interfere with the clinical evolution of some pigmentary lesions. This occurs in specific periods of life because of hormonal activity, such as that of growth hormone or estrogens during puberty and pregnancy. Exogenous hormones, for example from oral contraception and treatments for growth hormone deficiencies, can exert a marked influence on pigmentary lesions. In vivo and in vitro studies confirm this influence of exogenous hormones on melanocyte homeostasis. A recent study performed on children with growth disorders demonstrates the effect of growth hormone on melanocyte proliferation.¹ Estrogen receptors have been found in melanocytes whose prognostic value in the progression and metastases of melanoma is debatable.² However, there are no references in the medical literature to the possible influence of thyroid hormones on normal epidermal melanocytes and nevic cells, other than the well-known association between vitiligo and thyroid dysfunction.³ We describe . . . [Full Text of this Article]

Report of Cases

Case 1

Case 2

Comment